Table 2.
Gene set enrichment analysis of the HAG network in different human lung adenocarcinoma cohorts
GEO ID | Cohort description | Experimental groups | Enrichment analysis (adjusted P value) | |||
---|---|---|---|---|---|---|
HAG | PER | Thiol | SOD | |||
GSE21933 | 21 tumor tissues and adjacent normal tissue | Tumor versus normal tissue | 0.335 | 0.022* | 0.781 | 0.096 |
GSE41271 | 269 lung cancer specimens | Advanced versus early stagesa | 0.030* | 0.538 | 0.016* | 0.032* |
GSE42127 | 174 lung cancer specimens with clinicopathological information | Dead versus alive | 0.014* | 0.502 | 0.005** | 0.772 |
Transcript profiles of human lung adenocarcinoma patients were obtained from GEO. Nominal P value of enrichment analysis obtained from GSEA (P < 0.05)
HAG human antioxidant gene network, PER peroxidase gene set, Thiol thiol-containing gene set, SOD superoxide dismutase gene set
aPatients were grouped as early (I–II) or advanced (III–IV) clinical stages